Tenders Are Invited For Pharmaceutical Products – Antitumor And Endocrinological Substances (L01-L02)

Tender Detail

91415888
38044-2025
Self-Funded
Tenders Are Invited For Pharmaceutical Products – Antitumor And Endocrinological Substances (L01-L02)
NCB
Northern Europe
European Union
17-02-2025

Work Detail

Pharmaceutical Products – Antitumor And Endocrinological Substances (L01-L02). Cyclophosphamide,Ifosfamide,Temosolomiid,Methotrexate,Pemetrekseed,Fluorouratsiil,To Gemcitabine,Capecitabine,To Vinorelb,Etoposide, Concentrate For Solution For Infusion, 100Mg-200Mg In A Vial,Etoposide, Soft Capsule, 100Mg,Paclitaxel,Docetaxel,To Doxorubicin,Epirubicin,Mitomycin,Pertuzumab,Trastuzumab-Emtansine,Trastuzumab-Deruxtecan,Nivolumab, Concentrate For Solution For Infusion, 40Mg/4Ml,Nivolumab, Concentrate For Infusion Solution, 100Mg/10Ml,Nivolumab, Concentrate For Solution For Infusion, 240Mg/24Ml,Pembrolizumab,Durvalumab,Atesolizumab,Dostarlimab,Non-Platinum,Karboplatiin,Oxaliplatin,Estramustine,Of Course,Irinoteka,Lets Measure,To Eribuli,Pertuzumab + Trastuzumab,To Goserel,Fulvestrant,Belimumab, Solution For Injection In A Syringe Or Pen-Syringe, 200Mg,Belimumab, Powder For Concentrate For Infusion, 120Mg And 400Mg

Key Value

Tender Value
1,23,98,000 - EEK

Attachment

FileName File Description
Global Tender Document Tender Notice
Attachments
Additional Details Available on Click
✓ Tendering Authority
✓ Publication Document
(Tender Document / Tender Notice )
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
Tell us about your Product / Services,
We will Find Tenders for you

Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

For Tender Information Services Visit : TenderDetail